Topoisomerase II inhibitor 18
Topoisomerase II inhibitor 18 (Compound IV) is a Quinoxaline derivative, which inhibits topoisomerase II with IC50 of 7.5 μM. Topoisomerase II inhibitor 18 inhibits proliferation, cell cycle at S phase and induces apoptosis in PC-3 cells. Topoisomerase II inhibitor 18 reveals antitumor activity against cancer.
For research use only. We do not sell to patients.
- CAS No.: 2382959-65-9
- Formula: C20H21N3OS
- Molecular Weight:351.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Topoisomerase Isoforms
More
Biological Activity
Description
IC50 & Target
|
Topoisomerase II 7.5 μM (IC50) |
In Vitro
Topoisomerase II inhibitor 18 (0-100 μM) inhibits proliferations of cancer cells PC-3 and HepG2 with IC50s of 2.11 and 11.03 μM, without significant cytotoxicity in normal cells Vero (IC50 is 23.12 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:PC-3
-
Concentration:0-100 μM
-
Incubation Time:48 h
-
Result:Increased levels of p53, cleaved caspase-3 and cleaved caspase-8.
Decreased levels of Bcl-2.
-
Cell Line:HepG2, PC-3
-
Concentration:0-100 μM
-
Incubation Time:48 h
-
Result:Inhibited proliferations of PC-3 and HepG2
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Ehrlich solid tumor bearing albino mice[1]
-
Dosage:5 mg/kg
-
Administration:i.m. for 21 days
-
Result:Inhibited tumor growth.
Chemical Information
-
CAS No. 2382959-65-9
-
Molecular Weight 351.47
-
Formula C20H21N3OS
-
SMILES
O=C(NCCC)CCSC1=NC2=CC=CC=C2N=C1C3=CC=CC=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)